Keratosis, Actinic: all 369 studies
Page 4 of 4. Open to participants first (30), then studies with results posted, then the rest; newest registration first within each.
- Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant RecipientsTerminatedNCT01538901Phase 4
- Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic KeratosisCompletedNCT01516515Phase 2
- A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic KeratosesCompletedNCT01502020Not applicable
- Efficacy Study & Safety Evaluation of SR-T100 Gel in Actinic Keratosis TreatmentCompletedNCT01493921Phase 3
- Comparative Study of Photodynamic Therapy vs. CO2 Laser Therapy in Treatment of Actinic KeratosesStatus unknownNCT01481155Not applicable
- Comparison Between 5-aminolevulinic Acid Photodynamic Therapy Versus Cryotherapy for Actinic Keratosis TreatmentCompletedNCT01459393Phase 3
- Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2)CompletedNCT01453179Phase 4
- Development and Validation of a Quality of Life Instrument for Actinic KeratosisCompletedNCT01444989Not applicable
- Selenium in the Treatment of Arsenic Toxicity and CancersCompletedNCT01442727Phase 3
- Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic KeratosisStatus unknownNCT01413763Phase 4
- 5fluorouracil for Advanced PhotoagingStatus unknownNCT01405144Phase 3
- PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by HistologyCompletedNCT01387711Phase 1
- LAS41005 in Hyperkeratotic Actinic KeratosisCompletedNCT01358851Phase 2
- Bioequivalence Study of Generic Fluorouracil 0.5% Cream and 0.5% Carac® and PlaceboCompletedNCT01354717Phase 3
- PEP005 Gel - Evaluation of Local Tolerability After Exposure to Ingenol Mebutate Gel Followed by Hand Washing in Healthy SubjectsCompletedNCT01302925Phase 1
- Double-blind, Randomized, Vehicle- and Comparator-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of LAS41007 in the Treatment of Actinic KeratosisCompletedNCT01265602Phase 3
- Fractional CO2 Laser Assisted Photodynamic TherapyCompletedNCT01260987Phase 2/3
- Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic KeratosesStatus unknownNCT01229319Phase 4
- Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic KeratosisCompletedNCT01214564Phase 2
- Is Cryosurgery or Curettage More Effective at Treating Seborrheic Keratoses?CompletedNCT01159860Not applicable
- Imiquimod and Actinic Keratoses: an Observational StudyCompletedNCT01151956
- Efficacy and Safety Study of LAS41007 in the Treatment of Actinic KeratosisCompletedNCT00991861Phase 2
- A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 StudyCompletedNCT00989313
- Study on the Efficacy of LAS41005 in the Treatment of Actinic KeratosisCompletedNCT00987246Phase 3
- A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 StudiesCompletedNCT00953732
- A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 StudyCompletedNCT00952783
- A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities)CompletedNCT00917306Phase 3
- ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant RecipientsTerminatedNCT00865878Phase 2
- A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Three Imiquimod Cream 5% Treatments for Patients With Actinic KeratosisCompletedNCT00859105Phase 3
- A Study to Evaluate the Photoirritation Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy VolunteersCompletedNCT00850811Phase 1
- A Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy VolunteersCompletedNCT00850681Phase 1
- Photodynamic Therapy (PDT) Effect on Large Surface Photodamaged SkinCompletedNCT00843323Not applicable
- Phase II AK Study in Organ Transplant PatientsStatus unknownNCT00829192Phase 2
- Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic KeratosesWithdrawnNCT00814528Not applicable
- Long-term Effects of Imiquimod and Diclofenac in Actinic KeratosesCompletedNCT00777127Phase 4
- Photo-therapy With a Topical Retinoid Versus Photo-therapy Alone for Actinic KeratosesWithdrawnNCT00756288Not applicable
- A Randomized Multicenter Study of Daylight Mediated Photodynamic Therapy (PDT)CompletedNCT00711178Not applicable
- Potential Research Study Participant RegistryCompletedNCT00710489
- Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2CompletedNCT00659893Phase 1
- A Photodynamic Therapy for Treatment of Actinic KeratosesCompletedNCT00558688Not applicable
- A Study to Examine the Safety and Toleration of PEP005 Topical Gel in Patients With Actinic Keratoses on the Top of the HandCompletedNCT00544297Phase 2
- Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005CompletedNCT00544258Phase 1
- Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's DiseaseNo longer availableNCT00535080
- Treatment of Actinic Keratoses With Photodynamic Therapy Using Sunlight Versus Red LightCompletedNCT00432224Not applicable
- A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical GelCompletedNCT00427050Phase 2
- An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic KeratosesCompletedNCT00377273Phase 4
- Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic KeratosesCompletedNCT00375739Phase 2
- Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% CreamCompletedNCT00335179Phase 2
- PD P 506 A-PDT Versus Placebo-PDT and Cryosurgery for the Treatment of AKCompletedNCT00308867Phase 3
- Photodynamic Therapy With PD P 506 A Compared With Placebo-PDT for the Treatment of AKCompletedNCT00308854Phase 3
- Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and ScalpCompletedNCT00306800Phase 3
- Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis LesionsCompletedNCT00294320Phase 3
- Effect of IDEA-070 on Pain and Inflammation Induced by PDTCompletedNCT00269074Phase 2
- Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical GelCompletedNCT00239135Phase 2
- Cytodiagnosis of Basal Cell Carcinoma and Actinic Keratosis Using Papanicolaou and May-grunwald-giemsa Stained Tissue SmearCompletedNCT00218868
- Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and HeadCompletedNCT00204542Phase 4
- A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant RecipientsCompletedNCT00189267Phase 2
- A Study to Follow up Recurrence Rates of Actinic Keratoses One Year After Completion of Study 1487-IMIQCompletedNCT00189254
- Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic KeratosesCompletedNCT00175643Phase 3
- The Effect of Efudex Treatment on Photoaged SkinCompletedNCT00121511Not applicable
- Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and HandsCompletedNCT00115154Phase 4
- 1-Year Follow up to the 1473-IMIQ StudyCompletedNCT00114023
- Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic KeratosesCompletedNCT00110682Phase 4
- Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Actinic KeratosesCompletedNCT00107965Phase 2
- T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney TransplantCompletedNCT00089180Phase 2
- Celecoxib in Preventing Skin Cancer in Patients With Actinic KeratosesWithdrawnNCT00027976Phase 2/3
- Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic KeratosisCompletedNCT00021294Phase 2
- Green Tea Extract in Treating Patients With Actinic KeratosisTerminatedNCT00005097Phase 2
- T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma PigmentosumStatus unknownNCT00002811Phase 3